Samsung Biologics Market Cap

Samsung Biologics has a market cap or net worth of 81.8 trillion as of January 8, 2026. Its market cap has increased by 20.97% in one year.

Market Cap

81.80T

Enterprise Value

81.06T

Revenue

5.50T

Ranking

n/a

PE Ratio

51.26

Stock Price

1,885,000.00

Market Cap Chart

Since November 10, 2016, Samsung Biologics's market cap has increased from 9.53T to 81.80T, an increase of 758.50%. That is a compound annual growth rate of 26.44%.

Market Cap History

Date	Market Cap	% Change
Jan 7, 2026	81.80T	4.25%
Dec 30, 2025	78.46T	16.17%
Dec 30, 2024	67.54T	24.87%
Dec 28, 2023	54.09T	-7.43%
Dec 29, 2022	58.43T	-2.20%
Dec 30, 2021	59.75T	9.32%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Nov 10, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Celltrion	45.84T
ALTEOGEN	25.06T
ABL Bio	11.69T
SK Biopharmaceuticals	9.87T
Yuhan	8.55T
HLB Co., Ltd.	7.09T
LigaChem Biosciences	6.41T
Peptron	6.02T

Market Cap Rankings